1 July 2026Global biopharmaceutical company Ipsen is to acquire California-based clinical-stage biopharmaceutical company Kartos Therapeutics in a transaction valued at up to…- 1 July 2026Paris-based listed global biopharmaceutical company Ipsen SA has acquired Swiss biotechnology firm Memo Therapeutics AG in a deal that could…
26 June 2026Marc Kitten, co-founder and senior partner, Candesic, talks about his new book Private Equity in Healthcare and Life Sciences and…- 25 June 2026Merck, the Darmstadt-based science and technology giant, has entered into a definitive agreement to acquire Minneapolis-based Bio-Techne Corporation. This all-cash…
- 22 June 2026Listed US-based global biopharmaceutical company AbbVie has agreed to acquire clinical stage biotechnology firm Apogee Therapeutics in an all cash…
- 12 June 2026French private equity firm Motion Equity Partners has acquired a majority stake in Polaris, a Brittany-based biotechnology specialist renowned for…
- 9 June 2026GSK is to acquire Boston-based clinical-stage oncology specialist Nuvalent for an equity value of approximately $10.6bn. This marks the British…
- 1 June 2026Swiss contract development and manufacturing organisation CordenPharma is buying the US-headquartered peptide specialist AmbioPharm. The transaction will significantly bolster the…
- 27 May 2026A consortium led by CVC Capital Partners and Groupe Bruxelles Lambert has launched a voluntary cash tender offer to take…
- 25 May 2026New York-based PE Avista Healthcare Partners and the Belgium-based family office Damier Group have signed a definitive agreement to acquire…
